PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS

NCT06391905 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: PCSK9 inhibitor in combination with standard advanced first-line regimen group
DRUG: standard advanced first-line regimen group

Sponsor

Guangdong Provincial People's Hospital